Research Article
BibTex RIS Cite

Novel imidazole 2-amino pyrimidine deivatives: Insilico studies, evaluation of their anti-cancer activity against human-CDK2

Year 2023, Volume: 43 Issue: 4, 285 - 300, 01.12.2023
https://doi.org/10.52794/hujpharm.1177687

Abstract

In drug discovery process the identification of lead compounds by virtual screen- ing is a novel approach. From the literature it is understood that imidazoles and pyrimidines have gained much importance among the medicinal chemists because of their flexible structure and varied pharmacological activities. In present study imidazole and 2-amino pyrimidine derivatives were designed, subjected to the structure based virtual screenings in order to find the novel anticancer agents against human CDK2 protein. The molecular properties and molecular toxicity prediction was done using various online softwares like Molinspiration, Molsoft, OSIRIS, pkCSM along with bioactivity properties. The derivatives which exhibited drug like property were further subjected to molecular docking studies using Autodock Vina. Hits are identified, the basic pharmacophoric features responsible for the anticancer activity were predicted. Based on docking results the compound 24, which exhibited highest binding interaction with receptor will be further synthesized and can be novel lead for the development of anticancer agents.

References

  • Dr. Y. Rajendra Prasad Principal, Pharmaceutical Sciences, Andhra University, Vishakapatnam, Andhra Pradesh. mail. id: dryrp_au@rediffmail.com

Novel imidazole 2-amino pyrimidine deivatives: Insilico studies, evaluation of their anti-cancer activity against human-CDK2

Year 2023, Volume: 43 Issue: 4, 285 - 300, 01.12.2023
https://doi.org/10.52794/hujpharm.1177687

Abstract

In drug discovery process the identification of lead compounds by virtual screening is a novel approach. From the literature it is understood that imidazoles and pyrimidines have gained much importance among the medicinal chemists because of their flexible structure and varied pharmacological activities. In present study imidazole and 2-amino pyrimidine derivatives were designed, subjected to the structure based virtual screenings in order to find the novel anticancer agents against human CDK2 protein. The molecular properties and molecular toxicity prediction was done using various online softwares like Molinspiration, Molsoft, OSIRIS, pkCSM along with bioactivity properties. The derivatives which exhibited drug like property were further subjected to molecular docking studies using Autodock Vina. Hits are identified, the basic pharmacophoric features responsible for the anticancer activity were predicted. Based on docking results the compound 24, which exhibited highest binding interaction with receptor will be further synthesized and can be novel lead for the development of anticancer agents.

References

  • Dr. Y. Rajendra Prasad Principal, Pharmaceutical Sciences, Andhra University, Vishakapatnam, Andhra Pradesh. mail. id: dryrp_au@rediffmail.com
There are 1 citations in total.

Details

Primary Language English
Subjects Pharmacology and Pharmaceutical Sciences
Journal Section Research Articles
Authors

Navneetha Oleti 0000-0002-4238-4562

Munı Sıreesha Sunkara 0000-0003-4949-1712

Pranitha Kurella 0009-0003-0191-1586

Sahithi Manchı 0009-0000-7633-4718

Hemalatha Sattu 0000-0003-3721-6705

Publication Date December 1, 2023
Acceptance Date June 20, 2023
Published in Issue Year 2023 Volume: 43 Issue: 4

Cite

Vancouver Oleti N, Sunkara MS, Kurella P, Manchı S, Sattu H. Novel imidazole 2-amino pyrimidine deivatives: Insilico studies, evaluation of their anti-cancer activity against human-CDK2. HUJPHARM. 2023;43(4):285-300.